Lightspeed Venture Partners Closes on $1.8 Billion of Committed Capital
Early stage venture capital firm Lightspeed Venture Partners (“Lightspeed”) today announced the closings of Lightspeed Venture Partners XII, L.P. (“Fund XII”) with $750 million of committed capital and Lightspeed Venture Partners Select III, L.P. (“Select Fund III”) with $1.05 billion of committed capital.
Fund XII marks a continuation of Lightspeed’s strategy as an early stage investor (Seed, Series A and Series B) focused on accelerating disruptive innovations and trends in the Enterprise and Consumer sectors. Lightspeed has backed over 300 entrepreneurs and companies that have gone on to redefine the way people live and work.
Select Fund III will complement the firm’s early stage fund strategy with follow-on rounds in existing Lightspeed portfolio companies in their early growth phase (predominately Series C and beyond) as well as new investments in companies that have demonstrated compelling product-market fit, strong fundamentals and scalability.
Lightspeed has distributed in excess of $2.7B in portfolio realizations since the start of 2017 alone, including AppDynamics, Snap, MuleSoft, Nutanix and Stitch Fix among others. The momentum has continued in 2018 with the $6.5 billion Salesforce acquisition of MuleSoft in May, Zscaler IPO in March, and Forty Seven IPO in June. Of the more than 300 companies Lightspeed has partnered with since the firm’s founding, a third have either gone public or been acquired. More than 15 of those IPOs have occurred in the last decade alone.
Since its founding in 2000, Lightspeed has built a reputation as an early pioneer in enterprise investing in companies such as AppDynamics, Elementum, Exabeam, MuleSoft, Nimble Storage, Netskope, Nutanix, and Rubrik. For the past decade, Lightspeed’s rapidly scaling consumer practice has included investments in companies including Affirm, GIPHY, GrubHub, The Honest Company, Nest, Snap, Stitch Fix and Zola. Over 33% of the firm’s consumer investments over the past six years are in female-founded companies.
The partners of Lightspeed represent decades of company-building experience with technical expertise and a deep global network of relationships to help founders, including first-time CEOs, scale their businesses from the earliest stages of development to successful exits and beyond. Most recently, the firm welcomed the Chairman of Microsoft, John W. Thompson, and Semil Shah as Venture Partners, and Bradley Twohig and Natalie Luu as Partners.
Through its international presence and access to resources in Silicon Valley, Israel, China and India, the firm is able to help its portfolio companies tap into the talent and large market opportunities in those important geographies. The firm has a global mindset and is geographically diverse—notably, 80% of consumer investments at Lightspeed are outside the Bay Area.
Lightspeed currently manages over $6 billion of committed capital and is headquartered in Menlo Park, CA.
About Lightspeed
Lightspeed Venture Partners is an early stage venture capital firm focused on accelerating disruptive innovations and trends in the Enterprise and Consumer sectors. Over the past two decades, the Lightspeed team has backed hundreds of entrepreneurs and helped build more than 300 companies globally, including Snap, The Honest Company, GrubHub, Nest, Nutanix, AppDynamics, and MuleSoft. The firm currently manages over $6 billion of committed capital and invests in the U.S. and internationally, with investment professionals and advisors in Silicon Valley, Israel, India and China. www.lsvp.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180710005346/en/
Contact information
Lightspeed
Meredith Kendall
Marketing Partner
650-561-0764
meredith@lsvp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom